M3VAS Validation in Polish Population
Recruiting
Observational Study
Depressive Disorder
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 150 (estimated)
- Sponsor
- Medical University of Gdansk · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Low mood and anhedonia represent the fundamental symptoms of major depressive disorder (MDD). Nevertheless, there is currently no standardized visual analogue scale available to assess the extent of both symptoms concurrently. The Maudsley 3-item Visual Analogue Scale (M3VAS) is a newly developed tool for participants to self-assess core symptoms of depression: mood quality, pleasure experience (a…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Diagnosis as provided by DSM-5 criteria:
Major depressive disorder (MDD) Bipolar disorder (BD)
Exclusion Criteria:
Diagnosis as provided by DSM-5 criteria:
Psychotic disorders Current Mania or hypomania within bipolar disorder (BD)
Contacts
No contact information available.